Detalles de la búsqueda
1.
Non-invasive tests accurately stratify patients with NAFLD based on their risk of liver-related events.
J Hepatol
; 76(5): 1013-1020, 2022 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-35063601
2.
Disease burden and economic impact of diagnosed non-alcoholic steatohepatitis in five European countries in 2018: A cost-of-illness analysis.
Liver Int
; 41(6): 1227-1242, 2021 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-33590598
3.
Disease burden and economic impact of diagnosed non-alcoholic steatohepatitis (NASH) in the United Kingdom (UK) in 2018.
Eur J Health Econ
; 22(4): 505-518, 2021 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-33751289
4.
Preferences of patients with diabetes mellitus for inhaled versus injectable insulin regimens.
Pharmacoeconomics
; 26(3): 217-34, 2008.
Artículo
en Inglés
| MEDLINE | ID: mdl-18282016
5.
Cost-utility analysis of ledipasvir/sofosbuvir for the treatment of genotype 1 chronic hepatitis C in Japan.
Curr Med Res Opin
; 33(1): 11-21, 2017 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-27609424
6.
Cost-utility analysis of sofosbuvir for the treatment of genotype 2 chronic hepatitis C in Japan.
Curr Med Res Opin
; 33(1): 1-10, 2017 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-27608157
7.
Cost-utility analysis of vortioxetine versus agomelatine, bupropion SR, sertraline and venlafaxine XR after treatment switch in major depressive disorder in Finland.
Expert Rev Pharmacoecon Outcomes Res
; 17(3): 293-302, 2017 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-27680105
8.
Cost-effectiveness of sofosbuvir plus ribavirin with or without pegylated interferon for the treatment of chronic hepatitis C in Italy.
J Med Econ
; 18(9): 678-90, 2015.
Artículo
en Inglés
| MEDLINE | ID: mdl-25891129
9.
Systematic Literature Review and Meta-Analysis of Renal Function in Human Immunodeficiency Virus (HIV)-Infected Patients Treated with Atazanavir (ATV)-Based Regimens.
PLoS One
; 10(5): e0124666, 2015.
Artículo
en Inglés
| MEDLINE | ID: mdl-25938588
10.
Cost-effectiveness analysis of sofosbuvir compared to current standard treatment in Swiss patients with chronic hepatitis C.
PLoS One
; 10(5): e0126984, 2015.
Artículo
en Inglés
| MEDLINE | ID: mdl-25974722
11.
Systematic literature review and meta-analysis of diagnostic test accuracy in Alzheimer's disease and other dementia using autopsy as standard of truth.
J Alzheimers Dis
; 42(1): 169-82, 2014.
Artículo
en Inglés
| MEDLINE | ID: mdl-24840572
12.
Cost-effectiveness of telaprevir in combination with pegylated interferon alpha and ribavirin in previously untreated chronic hepatitis C genotype 1 patients.
J Med Econ
; 17(1): 65-76, 2014 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-24160335
13.
Cost-effectiveness of telaprevir in combination with pegylated interferon alpha and ribavirin in treatment-experienced chronic hepatitis C genotype 1 patients.
J Med Econ
; 17(1): 77-87, 2014 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-24032626
14.
Cost utility of telaprevir-PR (peginterferon-ribavirin) versus boceprevir-PR and versus PR alone in chronic hepatitis C in The Netherlands.
Appl Health Econ Health Policy
; 12(6): 647-59, 2014 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-25103219
15.
Chronic insomnia, quality-of-life, and utility scores: comparison with good sleepers in a cross-sectional international survey.
Sleep Med
; 13(1): 43-51, 2012 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-22093806
16.
Cost-effectiveness of highly purified omega-3 polyunsaturated fatty acid ethyl esters in the treatment of chronic heart failure: results of Markov modelling in a UK setting.
Eur J Heart Fail
; 13(6): 681-9, 2011 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-21474462
Resultados
1 -
16
de 16
1
Próxima >
>>